What’s the latest news in cancer research that stands out the most? In this post, I’ll briefly review several of the most interesting cancer research stories that have been in the news this summer.
These are a few of the recent stories that seem to have the greatest potential impact, at least from my perspective, and that I know I’ll want to follow as they develop further. Continue reading
Like many of us, I’ve long felt that one of the best ways to help in the fight against cancer is by making a donation to a charity that conducts or funds cancer research.
This post is the fourth in a series in which we’re taking a look at high quality charities that support cancer research as their main focus. In this post, we’ll review the Cancer Research Institute, including its mission and approach, history, notable financial facts and results reporting. Continue reading
2016 was not a year for big breakthroughs in cancer research and improving access to quality care. And yet, it was a year in which many of the issues that need to be addressed if we want to ever see those breakthroughs were front and center.
Those issues include the need for collaborative research and sustained research funding, finding ways to make immune system treatments safer and effective for more patients and addressing the problem of outrageously high drug prices. Continue reading
What’s exciting in cancer research right now? In this post, I’ll review several of the most interesting cancer research stories that have been in the news this summer.
These are a few of the recent stories that seem to have the greatest potential impact, at least from my perspective, and that I know I’ll want to follow as they develop further.
Stories worth following include several studies presented at the annual meeting of the American Society of Clinical Oncology (ASCO) in June. Among those were a study on extending the use of aromatase inhibitors in breast cancer treatment; findings that a web app boosts survival for patients with lung cancer; and, research on the use of a “biosimilar” treatment that can substitute for the breast cancer drug Herceptin. Continue reading
Many of us are interested in making donations in support of cancer research. But figuring out which organizations will make the most effective use of our contributions isn’t always an easy task. This post is the second in a series in which we’re looking at individual charities that focus primarily on cancer research.
Making a choice based on value for our money means considering factors such as how an organization uses the money it raises, its financial health, and how transparent it is about what has been accomplished with the contributions it has received.
In this post, we review the Breast Cancer Research Foundation, including its mission and approach, history, notable financial facts and results reporting. Continue reading
Many of us are interested in donating to organizations that support or conduct cancer research. But figuring out which organizations will make the most effective use of our contributions isn’t always an easy task.
Making a choice based on value for our money means considering factors such as how an organization uses the money it raises, its financial health, and how transparent it is about what has been accomplished with the contributions it has received.
This post is the first in an occasional series in which we’ll take a look at individual charities that focus primarily on cancer research–their history, mission, financial profiles and results reporting. We’ll start with Stand Up To Cancer, a program of the Entertainment Industry Foundation. Continue reading
What’s exciting in cancer research right now? In this post, I’ll review several of the most interesting cancer research stories that have been in the news this spring.
These are a few of the recent stories that seem to have the greatest potential impact, at least from my perspective, and that I know I’ll want to follow as they develop further.
Stories worth following include a potential new combination treatment for HER2-positive breast cancer, evidence from a large clinical trial of a gene assay that may help reduce unnecessary treatment, and a new study that offers some insights on male breast cancer. Continue reading
Looking back over the past year, what were some of the big things we learned that contribute to the progress that’s being made against cancer?
Here are ten of the stories that stood out most for me. Some involved new treatments or evolving treatment approaches. Others were about important policy issues, including the high costs of cancer care, and the pressing need for solutions. And again this year we were reminded of the importance of accuracy when it comes to reporting about celebrity cancer stories. Continue reading
What’s exciting in cancer research right now? In this post, I’ll review several of the most interesting cancer research stories that have been in the news this Fall.
These are a few of the recent stories that seem to have the greatest potential impact, at least from my perspective, and that I know I’ll want to follow as they develop further.
Stories to follow this Fall include the continuing developments in immune system therapies, the use of a gene assay to avoid unnecessary treatment and news of worsening trends in breast cancer disparities.
Continue reading
What’s exciting in cancer research right now? In this post, I’ll review several of the most interesting cancer research stories that have been in the news this Summer.
These are a few of the recent stories that seem to have the greatest potential impact, at least from my perspective, and that I know I’ll want to follow as they develop further.
The American Society of Clinical Oncology (ASCO) held its annual meeting in June. A major theme reflected in numerous reports about the meeting was the need for more intensive efforts to match patients with treatments based on the molecular characteristics of their cancer, and incorporating this approach into clinical trials. Continue reading
